Cargando…
Restriction of extracellular lipids renders pancreatic cancer dependent on autophagy
BACKGROUND: KRAS is the predominant oncogene mutated in pancreatic ductal adenocarcinoma (PDAC), the fourth cause of cancer-related deaths worldwide. Mutant KRAS-driven tumors are metabolically programmed to support their growth and survival, which can be used to identify metabolic vulnerabilities....
Autores principales: | Saliakoura, Maria, Sebastiano, Matteo Rossi, Nikdima, Ioanna, Pozzato, Chiara, Konstantinidou, Georgia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742413/ https://www.ncbi.nlm.nih.gov/pubmed/34998392 http://dx.doi.org/10.1186/s13046-021-02231-y |
Ejemplares similares
-
The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer
por: Saliakoura, Maria, et al.
Publicado: (2020) -
ACSL3–PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression
por: Rossi Sebastiano, Matteo, et al.
Publicado: (2020) -
Lipid Metabolic Alterations in KRAS Mutant Tumors: Unmasking New Vulnerabilities for Cancer Therapy
por: Saliakoura, Maria, et al.
Publicado: (2023) -
PLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxia
por: Saliakoura, Maria, et al.
Publicado: (2020) -
Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy
por: Rossi Sebastiano, Matteo, et al.
Publicado: (2019)